BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wibowo DP, Agustiningsih A, Jayanti S, Sukowati CHC, El Khobar KE. Exploring the impact of hepatitis B immunoglobulin and antiviral interventions to reduce vertical transmission of hepatitis B virus. World J Exp Med 2024; 14(4): 95960 [PMID: 39713069 DOI: 10.5493/wjem.v14.i4.95960]
URL: https://www.wjgnet.com/2220-315x/full/v14/i4/95960.htm
Number Citing Articles
1
A. V. Ivanov, O. V. Beliakova, A. I. Semicheva, T. V. Vyaznikova, E. I. Sakanjan, T. I. Smolyanova, А. R. Sokolova, D. M. Trofimov, A. M. Nikolaeva. Human hepatitis B immunoglobulin for intravenous administration: Development, quality control, viral safety, and pharmacokinetics researchBiological Products. Prevention, Diagnosis, Treatment 2025; 25(4): 400 doi: 10.30895/2221-996X-2025-25-4-400-412